2023
DOI: 10.1007/s11011-023-01222-6
|View full text |Cite
|
Sign up to set email alerts
|

Bio-synthesized selenium nanoparticles ameliorate Brain oxidative stress in Parkinson disease rat models

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 11 publications
(3 citation statements)
references
References 47 publications
0
3
0
Order By: Relevance
“…Moreover, the protective efficacy of SeNPs extends to neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis. A shared hallmark of SeNPs across these neurodegenerative conditions is their ability to suppress oxidative stress (Rajeshkumar et al, 2019;Salaramoli et al, 2023).…”
Section: Metallic Nanoparticles Such As Ionps Can Disrupt Iron Homeos...mentioning
confidence: 99%
“…Moreover, the protective efficacy of SeNPs extends to neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis. A shared hallmark of SeNPs across these neurodegenerative conditions is their ability to suppress oxidative stress (Rajeshkumar et al, 2019;Salaramoli et al, 2023).…”
Section: Metallic Nanoparticles Such As Ionps Can Disrupt Iron Homeos...mentioning
confidence: 99%
“…Hence, we inferred that Pb can down-regulate GSH and TAC, up-regulate MDA, and lead to oxidative stress in chicken Ces and Thi. Additionally, Salaramoli et al (2023) demonstrated that Se ameliorated oxidative stress in the brains of rats with Parkinson’s disease by up-regulating TAC and down-regulating MDA [ 18 ]. Se supplement relieved Cd-induced cerebral oxidative stress via increasing GSH and TAC and decreasing MDA in rabbits [ 19 ].…”
Section: Introductionmentioning
confidence: 99%
“…Also, patients encounter autonomic malfunctions with hypotension, defecation, urinary, and sleep disorders [ 2 ]. PD is identified by losing dopaminergic neurons in the substantia nigra pars compacta (SNpc), deposition and aggregation of alpha-synuclein ( α -Syn) into Lewy bodies, and neurites or oxidative stress [ 3 , 4 ]. Besides, glial neuroinflammatory reactions are contributed to degenerative procedures in PD [ 5 ].…”
Section: Introductionmentioning
confidence: 99%